Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Dendritic Cell-based Immunotherapy of Prostate Cancer: Immune Monitoring of a Phase II Clinical Trial

Patricia A. Lodge, Lori A. Jones, Robert A. Bader, Gerald P. Murphy, Michael L. Salgaller

Cancer Res (2000) 60 (4): 829–833.

Published: 01 February 2000

View article

Journal Articles

Correspondence re: Carl S. Killian et al. Prognostic Importance of Prostate-specific Antigen for Monitoring Patients with Stage B₂ to D₁ Prostate Cancer. Cancer Res., 45: 886–891, 1985—Reply

Carl S. Killian, Ming C. Wang, Gerald P. Murphy, T. Ming Chu

Cancer Res (1985) 45 (11_Part_2): 5984–5985.

Published: 01 November 1985

View article

Journal Articles

Prognostic Factors in Patients with Advanced Stage Prostate Cancer

Lawrence J. Emrich, Roger L. Priore, Gerald P. Murphy, Mark F. Brady, the Investigators of the National Prostatic Cancer Project

Cancer Res (1985) 45 (10): 5173–5179.

Published: 01 October 1985

View article

Journal Articles

Prognostic Importance of Prostate-specific Antigen for Monitoring Patients with Stages B₂ to D₁ Prostate Cancer

Carl S. Killian, Norman Yang, Lawrence J. Emrich, Farida P. Vargas, Manabu Kuriyama, Ming C. Wang, Nelson H. Slack, Lawrence D. Papsidero, Gerald P. Murphy, T. Ming Chu, the Investigators of the National Prostatic Cancer Project

Cancer Res (1985) 45 (2): 886–891.

Published: 01 February 1985

View article

Journal Articles

Selective Inhibition of Prostatic Tumor 5α-Reductase by a 4-Methyl-4-aza-steroid

Nobuyuki Kadohama, James P. Karr, Gerald P. Murphy, Avery A. Sandberg

Cancer Res (1984) 44 (11): 4947–4954.

Published: 01 November 1984

View article

Journal Articles

LNCaP Model of Human Prostatic Carcinoma

Julius S. Horoszewicz, Susan S. Leong, Elzbieta Kawinski, James P. Karr, Hannah Rosenthal, T. Ming Chu, Edwin A. Mirand, Gerald P. Murphy

Cancer Res (1983) 43 (4): 1809–1818.

Published: 01 April 1983

View article

Journal Articles

Use of Human Prostate-specific Antigen in Monitoring Prostate Cancer

Manabu Kuriyama, Ming C. Wang, Ching-li Lee, Lawrence D. Papsidero, Carl S. Killian, Hideo Inaji, Nelson H. Slack, Tsuneo Nishiura, Gerald P. Murphy, T. Ming Chu

Cancer Res (1981) 41 (10): 3874–3876.

Published: 01 October 1981

View article

Journal Articles

Quantitation of Prostate-specific Antigen in Serum by a Sensitive Enzyme Immunoassay

Manabu Kuriyama, Ming C. Wang, Lawrence D. Papsidero, Carl S. Killian, Takashi Shimano, Luis Valenzuela, Tsuneo Nishiura, Gerald P. Murphy, T. Ming Chu

Cancer Res (1980) 40 (12): 4658–4662.

Published: 01 December 1980

View article

Journal Articles

Isolation of Prostatic Acid Phosphatase-binding Immunoglobulin G from Human Sera and Its Potential for Use as a Tumor-localizing Reagent

Lawrence D. Papsidero, John W. Wojcieszyn, Julius S. Horoszewicz, Susan S. Leong, Gerald P. Murphy, T. Ming Chu

Cancer Res (1980) 40 (8_Part_2): 3032–3035.

Published: 01 August 1980

View article

Journal Articles

A Prostate Antigen in Sera of Prostatic Cancer Patients

Lawrence D. Papsidero, Ming C. Wang, Luis A. Valenzuela, Gerald P. Murphy, T. Ming Chu

Cancer Res (1980) 40 (7): 2428–2432.

Published: 01 July 1980

View article

Journal Articles

Purification and Characterization of Acid Phosphatase from Dunning R3327H Prostatic Adenocarcinoma

Ching-li Lee, Gerald P. Murphy, T. Ming Chu

Cancer Res (1980) 40 (4): 1245–1248.

Published: 01 April 1980

View article

Journal Articles

Introduction to the Leukocyte Adherence Inhibition Workshop

Gerald P. Murphy

Cancer Res (1979) 39 (2_Part_2): 555.

Published: 01 February 1979

View article

Journal Articles

A Solid-Phase Fluorescent Immunoassay for Human Prostatic Acid Phosphatase

Ching-li Lee, Ming Chang Wang, Gerald P. Murphy, T. Ming Chu

Cancer Res (1978) 38 (9): 2871–2878.

Published: 01 September 1978

View article

NARROW

Dendritic Cell-based Immunotherapy of Prostate Cancer: Immune Monitoring of a Phase II Clinical Trial

Correspondence re: Carl S. Killian et al. Prognostic Importance of Prostate-specific Antigen for Monitoring Patients with Stage B₂ to D₁ Prostate Cancer. Cancer Res., 45: 886–891, 1985—Reply

Prognostic Factors in Patients with Advanced Stage Prostate Cancer

Prognostic Importance of Prostate-specific Antigen for Monitoring Patients with Stages B₂ to D₁ Prostate Cancer

Selective Inhibition of Prostatic Tumor 5α-Reductase by a 4-Methyl-4-aza-steroid

LNCaP Model of Human Prostatic Carcinoma

Use of Human Prostate-specific Antigen in Monitoring Prostate Cancer

Quantitation of Prostate-specific Antigen in Serum by a Sensitive Enzyme Immunoassay

Isolation of Prostatic Acid Phosphatase-binding Immunoglobulin G from Human Sera and Its Potential for Use as a Tumor-localizing Reagent

A Prostate Antigen in Sera of Prostatic Cancer Patients

Purification and Characterization of Acid Phosphatase from Dunning R3327H Prostatic Adenocarcinoma

Introduction to the Leukocyte Adherence Inhibition Workshop

A Solid-Phase Fluorescent Immunoassay for Human Prostatic Acid Phosphatase

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only